Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2

by Anders Carey, Blackwell Kimberly L, Marcom Paul, Niedzwiecki Donna, Osada Takuya, Hobeika Amy, Morse Michael A, Devi Gayathri R, Lyerly H Kim, Clay Timothy M
Published 2007-09-01

Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion

by Hamilton Erika, Blackwell Kimberly, Hobeika Amy C, Clay Timothy M, Broadwater Gloria, Ren Xiu-Rong, Chen Wei, Castro Henry, Lehmann Frederic, Spector Neil, Wei Junping, Osada Takuya, Lyerly H Kim
Published 2012-02-01

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

by Valente Nancy, Clay Timothy M, Hobeika Amy, Khan Shubi, Osada Takuya, Garst Jennifer, Morse Michael A, Shreeniwas Revati, Sutton Mary, Delcayre Alain, Hsu Di-Hwei, Le Pecq Jean-Bernard, Lyerly H Kim
Published 2005-02-01